Study guide
2.4 Age-Specific Screening Schedules
ANCC Family Nurse Practitioner FNP-BC
Track your progress as you read
Finished sections get a check mark.
1 Introduction & Exam Overview
1.1 Current Exam Facts 1.2 Eligibility, Application, and Test Day 1.3 Blueprint Weights, TCO Dates, and Study Strategy
2 Assessment Foundations
2.1 Population Health Promotion and Screening 2.2 Comprehensive History and Physical 2.3 Focused History and Physical 2.4 Age-Specific Screening Schedules
3 Function, Risk, and Lifespan Assessment
3.1 Functional Assessment 3.2 Risk Assessment and Social Determinants 3.3 Pediatric Developmental Assessment 3.4 Adolescent, Adult, and Geriatric Assessment
4 Diagnosis Foundations
4.1 Pathogenesis and Pathophysiology 4.2 Diagnostic Test and Procedure Selection 4.3 Interpreting Labs and Imaging 4.4 Normal vs Abnormal Physiologic Change
5 Differential Diagnosis
5.1 Formulating Differential Diagnoses 5.2 Red Flags and Emergency Identification 5.3 Diagnostic Reasoning Traps
6 Prevention and Anticipatory Guidance
6.1 Primary, Secondary, and Tertiary Prevention 6.2 Pediatric and Adolescent Anticipatory Guidance 6.3 Adult and Geriatric Anticipatory Guidance 6.4 Immunization Planning Across the Lifespan
7 Guidelines, Culture, and Evidence
7.1 Crisis, Safety, and End-of-Life Planning 7.2 Clinical Guidelines and Standards of Care 7.3 Culturally and Ethnically Sensitive Practice 7.4 Evidence-Based Research Appraisal
8 Care Plans and Shared Decisions
8.1 Shared Decision-Making 8.2 Multimorbidity and Prioritization 8.3 Referral, Comanagement, and Transitions
9 Pharmacotherapeutics
9.1 Pharmacokinetics, Pharmacodynamics, and Pharmacogenetics 9.2 Interactions, Contraindications, and Monitoring 9.3 Special-Population Prescribing 9.4 High-Alert Medications and Analgesic Safety
10 Cardiovascular Primary Care
10.1 Cardiovascular Diagnosis 10.2 Cardiovascular Pharmacotherapy 10.3 Nonpharmacologic Cardiovascular Management 10.4 Lifespan Cardiovascular Issues
11 Respiratory Primary Care
11.1 Respiratory Diagnosis 11.2 Respiratory Pharmacotherapy 11.3 Lifespan Respiratory Care
12 Endocrine and Metabolic Primary Care
12.1 Diabetes Diagnosis and Monitoring 12.2 Diabetes Pharmacotherapy 12.3 Thyroid and Other Endocrine Disorders 12.4 Obesity and Metabolic Disease
13 Gastrointestinal Primary Care
13.1 Gastrointestinal Diagnosis 13.2 GI Pharmacotherapy and Nutrition 13.3 Lifespan Gastrointestinal Care
14 GU, Renal, and Reproductive Primary Care
14.1 GU and Renal Diagnosis and Management 14.2 Women's Reproductive Health 14.3 Pregnancy and Postpartum Primary Care 14.4 Men's Health and Sexual Function
15 HEENT, Skin, and Musculoskeletal
15.1 HEENT Diagnosis and Management 15.2 Integumentary Diagnosis and Management 15.3 Musculoskeletal Diagnosis 15.4 MSK Procedures and Nonpharmacologic Care
16 Neuro, Psych, Heme, Immune, and Infection
16.1 Neurological Diagnosis and Management 16.2 Psychiatric Diagnosis and Substance Use 16.3 Hematopoietic and Immune Disorders 16.4 Common Infections and Anti-Infectives
17 Clinical Delivery Skills
17.1 Office Procedures and Nonpharmacologic Treatment 17.2 Patient-Specific Education 17.3 Therapeutic Communication 17.4 Comprehensive Documentation
18 Professional Practice
18.1 Legal and Ethical Implications 18.2 Health IT, EHR, and AI Ethics 18.3 Regulatory Guidelines: Reportable Disease and Abuse 18.4 APRN Scope, Standards, and FNP Role
19 Outcome Evaluation
19.1 Ethical and Legal Evaluation Issues 19.2 Pharmacotherapeutic Outcome Monitoring 19.3 Nonpharmacologic Outcome Monitoring 19.4 Clinical Data, PROs, and Treatment Efficacy
20 Follow-Up, Systems, and Exam Strategy
20.1 Follow-Up Intervals and Surveillance 20.2 Treatment Adjustment and Deprescribing 20.3 Resource Management and Care Coordination 20.4 Exam-Day Strategy and TCO Review
2.4 Age-Specific Screening Schedules
Key Takeaways Explain This Topic AI
Map screens to the official FNP age groups — infant, preschool, school-age, adolescent, young adult, adult, older adult, frail elderly — and name the authority (Bright Futures, USPSTF, ACIP, obstetric guidelines).
Newborn assessment includes the state metabolic panel, hearing, critical congenital heart disease pulse oximetry, bilirubin risk, and hip exam; M-CHAT-R/F belongs at 18 and 24 months.
Cervical screening starts at 21, not at coitarche; AAP/NHLBI lipids are once at 9–11 and once at 17–21, while USPSTF still has an I statement for routine childhood lipid screening.
Adult calendars follow Section 2.1, plus a one-time AAA ultrasound in men 65–75 who have ever smoked; do not invent unpublished intervals or a required PSA start age.
Frailty changes the net-benefit horizon: add falls, cognition, hearing, vision, osteoporosis, and a deprescribing look at the medication list rather than restarting a midlife cancer calendar.
Last updated: August 2026
The FNP-BC secondary classifications use eight age groups : infant, preschool, school-age, adolescent, young adult, adult, older adult, and frail elderly. Screening calendars change at those seams. You are not expected to memorize every Bright Futures checkbox. You are expected to pick the right package for the age , name the authority (USPSTF versus Bright Futures versus ACIP versus obstetric guidelines), and avoid two errors: starting adult cancer screens too early, and treating a frail 88-year-old as if she were a 55-year-old with a 30-year horizon. If an interval is not published by a named guideline, teach the decision rule and the uncertainty — do not invent a memorable number.
Newborn and infant
Before discharge and in the first weeks, confirm that the nursery actually completed the screens — a “normal stay” is not proof.
Newborn metabolic and endocrine blood spot (state panel: PKU, congenital hypothyroidism, hemoglobinopathies, and others that vary by state ). Review the result; do not assume the card left the hospital.
Newborn hearing screen; refer fails promptly.
Critical congenital heart disease (CCHD) pulse-oximetry screen.
Bilirubin risk assessment with transcutaneous or serum measurement before discharge and early follow-up for jaundice.
Developmental dysplasia of the hip : Ortolani and Barlow in the newborn period; later limited abduction and Galeazzi. Image when risk factors persist (breech, family history, unstable exam) according to AAP imaging guidance — do not invent a universal ultrasound week for every infant.
Growth at every visit: weight, length, head circumference, plotted on WHO charts from birth to 2 years.
Through infancy, perform developmental surveillance every visit and standardized developmental screening at Bright Futures intervals (commonly 9, 18, and 30 months). Add autism-specific screening with M-CHAT-R/F at 18 and 24 months . Assess anemia risk and obtain hemoglobin around 12 months in typical well-child pathways. Lead is targeted by risk (housing built before 1978, sibling with lead poisoning, immigrant or refugee background). Many Medicaid programs still require 12- and 24-month blood lead levels — follow the coverage rule in front of you. USPSTF has an I statement for screening asymptomatic children for elevated lead; do not call lead a USPSTF Grade A universal test. Vision and hearing begin with history and observation; formal vision charts come later. Oral health: first dental home by 12 months and fluoride varnish in the medical home when indicated. Immunizations follow ACIP ; reconstruct catch-up conceptually and leave the full tables for the immunization chapter. Vitamin D for exclusively or partially breastfed infants and iron guidance belong with nutrition and anticipatory guidance, but the assessment step is asking how the infant is fed.
Preschool and school-age
Preschool (about 3–5 years) adds routine blood pressure from age 3 , age-appropriate vision charts, hearing when feasible, dental surveillance, growth, school-readiness development, and ongoing lead risk. School-age visits track BMI trajectory, vision and hearing, dental health, sleep, bullying and safety, and lipids . AAP/NHLBI: universal lipid screening once at 9–11 years and again at 17–21 , with earlier targeted testing if a parent had early CVD, familial hypercholesterolemia is known, or the child has diabetes, hypertension, BMI at or above the 95th percentile, or smokes. USPSTF: I statement for routine childhood lipid screening. If the item cites USPSTF, do not claim a Grade A universal child lipid test.
Adolescent and young adult
HEADSS (Home, Education/employment, Eating, Activities, Drugs, Sexuality, Suicide/depression/Safety) is the adolescent assessment frame. Build confidential time into the visit before you skip the history because a parent is in the room.
Depression screening (USPSTF ages 12–18, Grade B; continue into young adulthood).
Anxiety screening (USPSTF ages 8–18, Grade B).
STI and HIV based on sexual history. HIV at least once in the 15–65 band; more often with risk.
Cervical screening starts at 21 , not at first intercourse, not at HPV-vaccine completion, and not at 18 “because she is at college.”
Lipids once at 17–21 on the AAP/NHLBI calendar.
Firearms, substances, and intimate-partner safety questions belong here even when the “reason for visit” is a sports form.
Young adults (roughly 18–39) inherit adult USPSTF A/B items that start at 18 — blood pressure, depression, alcohol, HIV, HCV once between 18 and 79 — while average-risk breast and colorectal screens have not yet begun. Cervical screening starts at 21. High-risk patients (BRCA pathway, longstanding ulcerative colitis, heavy tobacco starting in adolescence) leave the average-risk calendar early; that is individual-risk reasoning from Section 2.1, not a license to start mammography on every 28-year-old.
Adult
Apply Section 2.1 as a calendar , not a trivia list.
Age band High-yield average-risk screens
21–39 Cervical per 2.1; BP; depression and anxiety; alcohol; HIV; HCV once; tobacco; STI as indicated; begin thinking about lipids and future 10-year CVD risk
40–49 Add biennial mammography (40–74) ; colorectal screening starting at 45 ; continue cervical; begin the statin assessment (risk factors plus 10-year risk)
50–64 Continue the above; annual LDCT if 50–80 + 20 pack-years + current smoker or quit <15 years ; colorectal screening through 75
65–75 Add osteoporosis in women ≥65 ; one-time AAA ultrasound in men 65–75 who have ever smoked ; decide when to stop cervical screening after adequate prior normals; mammography through 74; colorectal through 75; review LDCT stop rules
Do not invent a required PSA start age. USPSTF: men 55–69 Grade C (selectively offer after shared decision); 70 and older Grade D . If the stem does not give that frame, do not auto-order PSA. Do not invent annual “wellness labs” (CBC, CMP, TSH) as USPSTF screens — those are diagnostic or case-finding tools unless a specific recommendation applies.
Older adult and frail elderly
Chronologic age 65 and older is not frailty. Frailty is decreased reserve — weight loss, exhaustion, slowness, weakness, low activity — and it changes the net-benefit horizon . Assessment-stage additions:
Falls. Ask about falls in the past year, gait, and assistive devices; watch the patient rise from a chair.
Cognition. Screen when the patient, family, or function raises concern. Many AWV workflows include a structured cognitive screen even without a complaint.
Hearing and vision. Under-recognized drivers of falls, isolation, and “cognitive” complaints.
Osteoporosis in women 65 and older if not already done. A fracture history in a man may still justify testing even though USPSTF lacks a universal male Grade B start age.
Deprescribing opportunity. The comprehensive or AWV medication list is the assessment moment to flag anticholinergics, stacked antihypertensives, sliding-scale-only insulin in a frail eater, and NSAIDs in CKD. You are not writing the taper in this chapter — you are noticing the risk.
Stop rules. Do not reflexively continue colorectal screening after 85, LDCT after limited life expectancy or loss of surgical candidacy, mammography as if the 40–74 Grade B still applies unchanged after 75 (I statement), or cervical screening after adequate history and hysterectomy for benign disease.
Pregnancy as family-NP scope
Family NPs assess pregnancy in primary care. Confirm pregnancy, date by LMP and the ultrasound pathway, and open a different screening calendar the same day : HIV, syphilis, hepatitis B, blood type and Rh, CBC, urine, rubella immunity, and other obstetric-panel items per current obstetric guidelines; offer aneuploidy-screening options rather than a single invented test; identify SDOH and intimate-partner violence; review teratogens and immunization status (inactivated influenza when indicated, Tdap timing, and what must wait). Detailed obstetric protocols belong in the pregnancy chapter. The assessment skill is this: a positive home pregnancy test is not a wellness add-on.
One calendar, many authorities
Age group Typical home Dominant authority Do not invent
Newborn / infant Nursery plus 3–5 days, then 1, 2, 4, 6, 9, 12 months Bright Futures, state newborn screen, ACIP A universal USPSTF Grade A lead age
- Preschool 15, 18, 24, 30 months; 3–4 years Bright Futures; M-CHAT-R/F at 18 and 24 months Adult cancer screens
- School-age Annual well child Bright Futures; AAP/NHLBI lipids at 9–11 USPSTF Grade A childhood lipids
Adolescent Annual well visit with confidential time HEADSS, USPSTF mental-health and STI items, ACIP Pap before 21
Young adult Preventive plus problem mix USPSTF adult A/B from 18; Pap at 21 Mammogram or colorectal screening early without individual risk
Adult Periodic wellness USPSTF 2024–2026 items in Section 2.1 Annual “full labs” as a screen
Older adult AWV plus problem visits USPSTF plus stop rules plus AAA in eligible men Screening the patient cannot survive treatment for
Frail elderly Goal-concordant visits Function, falls, cognition, senses, bone, medications The same calendar used at age 55
Vignette. A 14-year-old is in for a sports physical with a parent in the room. The FNP who only listens to the heart and signs the form has not done an age-specific assessment. Confidential HEADSS time, a depression screen, a sexual and substance history, firearm storage, and a decision not to perform a Pap are the Domain I moves. Contrast that with an 88-year-old who wants to “catch up on everything.” She had a normal colonoscopy at 78 and a mammogram at 76. The correct assessment is frailty, falls, cognition, hearing, vision, bone health, and the medication list — not a restart of midlife cancer screening because someone handed her a checklist.